Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03958734 · ClinicalTrials.gov registry record · NA

Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals - Study 1

A NA study of Cardiovascular Risk Factor and Lipemia, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
59
Enrollment target
1
Study location

NCT03958734 is a NA study of Cardiovascular Risk Factor and Lipemia that has completed, run by Virginia Commonwealth University. The registered enrollment target is 59 participants, below the 3,066-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03958734, a NA study of Cardiovascular Risk Factor and Lipemia, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to examine the effect of high-fat meals on the health of blood vessels. In addition, the study will examine how exercise/fitness/physical activity impacts blood vessels after consumption of a high-fat meal.

Interventions

  • OTHER High-fat meal

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2019-06-17
Est. Completion 2021-04-29
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT03958734

The ClinicalTrials.gov registry entry for NCT03958734 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,066-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (98% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiovascular Risk Factor appearing as the primary indexed condition, and to 1 intervention - of which High-fat meal is the first listed.

NCT03958734 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT03958734 about?

NCT03958734 is a clinical study titled "Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals - Study 1". The purpose of this research study is to examine the effect of high-fat meals on the health of blood vessels. In addition, the study will examine how exercise/fitness/physical activity impacts blood vessels after consumption of a high-fat meal.

What is the current status of trial NCT03958734?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2019-06-17. Estimated completion is 2021-04-29.

What conditions does trial NCT03958734 study?

This clinical trial studies the following conditions: Cardiovascular Risk Factor, Lipemia.

What interventions are being tested in trial NCT03958734?

The interventions under investigation include: High-fat meal (OTHER).

Who is sponsoring clinical trial NCT03958734?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03958734 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Risk Factor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.